Disclosures for "Cladribine for the Treatment of Relapsing Multiple Sclerosis: The Northern Ireland Experience"
-
Dr. Philson has received personal compensation in the range of $500-$4,999 for serving as a Educational Programme Participant with Roche.
-
Dr. Kee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Kee has received personal compensation in the range of $500-$4,999 for serving as a Travel and educational support with Roche.
-
Author has nothing to disclose
-
Dr. Campbell has nothing to disclose.
-
Dr. Gray has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Gray has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Gray has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase.
-
Dr. McDonnell has nothing to disclose.
-
Dr. Hughes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hughes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Hughes has received personal compensation in the range of $500-$4,999 for serving as a Meeting Chair with Merck. Dr. Hughes has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Biogen. Dr. Hughes has received personal compensation in the range of $500-$4,999 for serving as a Meeting Chair with Roche. Dr. Hughes has received personal compensation in the range of $500-$4,999 for serving as a Conference Delegate with Roche.
-
Dr. Kennedy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kennedy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kennedy has received personal compensation in the range of $500-$4,999 for serving as a Meeting chair with Neuraxpharm. Dr. Kennedy has received personal compensation in the range of $500-$4,999 for serving as a Meeting chair with Roche. Dr. Kennedy has received personal compensation in the range of $0-$499 for serving as a Meeting chair with Merck. Dr. Kennedy has received personal compensation in the range of $500-$4,999 for serving as a Conference delegate with Sanofi. Dr. Kennedy has received personal compensation in the range of $500-$4,999 for serving as a Conference delegate with Novartis. Dr. Kennedy has received personal compensation in the range of $500-$4,999 for serving as a Conference delegate with Roche.